Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer

By sjmartinez • October 11, 2024

Chow F, Lamoureux F, Moriceau G. Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer. Front Immunol. 2024 Sep 26;15:1487952. doi: 10.3389/fimmu.2024.1487952. PMID: 39391312; PMCID: PMC11464455.

Tags: ADC, antibody drug conjugate, Cancer, combination therapy, Dermatology, Drug resistance, immunotherapy, next generation therapeutics, Publications, targeted therapy

Update on Absorbable Facial Thread Lifts

Riopelle AM, Geisler AN, Eber A, Dover JS. Update on Absorbable Facial Thread Lifts. Dermatol Surg. 2024 Dec 11. doi: 10.1097/DSS.0000000000004521. Epub ahead of print.[...]

Unusual Cutaneous Metastasis in a Patient with Cholangiocarcinoma

Dong E, Yashar S, Mandelkern M, Kaunitz J. Unusual Cutaneous Metastasis in a Patient with Cholangiocarcinoma. Dig Dis Sci. 2024 Dec 11. doi: 10.1007/s10620-024-08775-1. Epub[...]

Sexual Dysfunction in Chronic Urticaria: A Systematic Review

Park SE, Ma E, Dagenet C, Aleshin MA, Holahan HM, Shi VY, Hsiao JL. Sexual Dysfunction in Chronic Urticaria: A Systematic Review. Dermatol Ther (Heidelb).[...]